You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 18 Mar 2024
Cancer Type:
Endocrine, 
Thyroid
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Mar 2024
Regimen
Published Date: 18 Mar 2024
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Intent: Curative
Revision Summary:

Regimen Monograph: Removed funding information for thiotepa

Updated
Mar 2024
Regimen
Published Date: 08 Mar 2024
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale and Uses, Cycle Frequency, and Antiemetic Regimen information; added NDFP form

Updated
Mar 2024
Drug

Published Date: 08 Mar 2024

Revision Summary:


Drug Monograph: Modified Emetogenic potential section; added NDFP form

Updated
Mar 2024
Regimen
Published Date: 08 Mar 2024
Cancer Type:
Gastrointestinal, 
Hepatobiliary / Liver / Bile Duct
Intent: Palliative
Revision Summary:

Regimen Monograph: Expanded into full regimen monograph

Updated
Mar 2024
Regimen
Published Date: 08 Mar 2024
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Antiemetic Regimen information

Updated
Mar 2024
Regimen
Published Date: 08 Mar 2024
Cancer Type:
Lung, 
Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Dosage in hepatic impairment, Adverse effects, Drug administration, Pregnancy/lactation and Monitoring sections

Updated
Mar 2024
Regimen
Published Date: 08 Mar 2024
Cancer Type:
Lung, 
Non-Small Cell
Intent: Curative
Revision Summary:

Regimen Monograph: Modified Dosage in hepatic impairment, Adverse effects, Drug administration, Pregnancy/lactation and Monitoring sections

Updated
Mar 2024
Drug

Published Date: 08 Mar 2024

Revision Summary:
Drug Monograph: Modified Indications, Adverse effects, Dosage in hepatic impairment, and Monitoring sections
Patient Info Sheet EN: Updated/revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Updated
Mar 2024
Regimen
Published Date: 08 Mar 2024
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Dosage in hepatic impairment, Adverse effects, Drug administration, Pregnancy/lactation and Monitoring sections

Updated
Mar 2024
Drug

Published Date: 07 Mar 2024

Revision Summary:
Drug Monograph: New drug monograph
Patient Info Sheet EN: New patient information sheet
Updated
Mar 2024
Regimen
Published Date: 07 Mar 2024
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Revision Summary:

Regimen Monograph: Expanded into full regimen monograph

Updated
Mar 2024

Pages